PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...
Ocular Therapeutix (OCUL) stock surges on rumors that Sanofi (SNY) is readying an improved bid to take over the company. Read ...
Providers, state health agencies and others are feeling whiplash and confusion after the Trump administration eliminated and ...
Arizona lawmakers are moving in a bipartisan fashion to restrict the ability of corporations and investors to buy up ...